Grapevine, TX
$115K On Target Earnings (Year 1)
——————
CureTech is a leading provider of advanced therapy solutions for lymphedema management and post-surgical recovery.
We partner with vascular specialists, rehabilitation providers, and surgical centers to improve patient outcomes—while simplifying how therapy is delivered.
Today, 200+ ambulatory surgery centers, 1,000+ prescribers, and over 200,000 patients nationwide rely on CureTech to extend care beyond the clinic and into the home.
Our model combines advanced therapy solutions with a streamlined digital platform—giving providers real-time visibility and helping patients access care faster.
As demand for lymphedema therapy continues to grow, we’re expanding our Clinical Therapies team to build and scale high-performing territories across the country.
CureTech is seeking an Area Sales Manager (ASM) to own and expand a defined territory within our Clinical Therapies Sales Team, focused on lymphedema therapy.
This is a high-impact expansion role—building new clinical partnerships while driving measurable growth across an established, opportunity-rich market.
You’ll develop your territory by driving adoption across key specialties.
This isn’t a single-product role. You are building something that compounds.
You’ll introduce a full therapy pathway, supported by a broad DME portfolio—creating multiple revenue streams within each account.
Preferred:
High performers don’t just get a territory—they’re backed to execute.
We invest heavily in the people driving our growth. That means real support in the field, access to leadership, and the infrastructure needed to scale accounts efficiently.
As you build momentum, additional resources are aligned to help you expand faster, operate smarter, and maximize output within your territory.
You’re not left to figure it out—you’re positioned to win.
If you’re looking for autonomy, upside, and the ability to create something meaningful in your market—this is where it happens.
This is a build-your-business role inside a company that’s scaling fast.
What to expect: